BLOG

Although clinicians have successfully used CAR-T cells in cancer, many

One of the main limitations of CAR-T cells is that

CAR-T therapy treatments have proven effective in patients with blood

The CRISPR-Cas9 molecular complex is the tool most widely used

Researchers at the University of Tokyo have developed a groundbreaking

With continued exposure to tumours, T lymphocytes progressively lose their

Current methods of activating T cells do not sufficiently mimic the natural

In the fight against cancer, CAR-T cells have achieved remarkable

Glioblastoma is the most common and aggressive primary brain tumor,